Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Lexington, Massachusetts 02421


Purpose:

The purpose of this study is to compare the difference between two magnetic resonance imaging (MRI) techniques for visualizing arteries. The study hypothesizes that one method that relies upon imaging flowing blood in the pelvic and leg arteries will not be as accurate or efficient as injecting a safe imaging agent to change the appearance of the blood on the MRI. Both methods will be compared with Digital Subtraction Angiography (DSA).


Criteria:

Inclusion Criteria: - Subjects with symptoms of PAD - Scheduled for DSA Exclusion Criteria: - Critical leg ischemia manifested by ulcers, gangrene or leg amputation - Laboratory evidence of iron overload, liver disease, pregnancy - History of allergy to or recent exposure to radiocontrast, gadolinium chelates, or intravenous iron therapy - Clinical concerns about co-morbidities, subject suitability


NCT ID:

NCT00707876


Primary Contact:

Study Director
William Strauss, MD
AMAG Pharmaceuticals, Inc.


Backup Contact:

N/A


Location Contact:

Lexington, Massachusetts 02421
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 18, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.